Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.40 |
| ▸ | NPY4R | P50391 | 7/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | NPY2R | P49146 | 4/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.36 |
| ▸ | RRM1 | P23921 | 1/20 | 0.36 |
| ▸ | OTC | P00480 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9330200 | 1.00 | DPP7 (0.42) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| SCHEMBL93606 | 1.00 | DPP7 (0.42) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL569999 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL2897702 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL1487716 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL570000 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL22411245 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Water SCHEMBL28810239 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| SCHEMBL31592761 | 0.98 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Pimagedine SCHEMBL3189711 | 0.95 | DPP7 (0.40) | DPP7NOD1NPY4RNPY1RGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1919 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630661-B2 | Additives useful in 3D printing technologies | Evonik Operations GmbII (DE) | 2026-05-19 | — | — | US | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| EP-4737581-A1 | NOVEL SPERMIDINE AND AGMATINE PRODUCING BACILLUS STRAINS | Evonik Operations GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4731755-A2 | COMPOSITIONS AND METHODS FOR REDUCING HOST CELL PROTEINS IN RECOMBINANT ADENO-ASSOCIATED VIRUS PREPARATIONS | Ultragenyx Pharmaceutical Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4720322-A2 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | CELYNTRA THERAPEUTICS SA (BE) | 2025-12-25 | — | — | US | claimed |
| EP-4601623-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2025-08-20 | — | — | EP | claimed |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | YU RUEY J (US) | 2002-03-07 | — | — | US | claimed |
| US-6335023-B1 | VEHICLES AND OLIGOSACCHARIDE ALDONIC ACIDS | YU RUEY J (US) | 2002-01-01 | — | — | US | claimed |
| EP-1156812-A1 | MULTIPARTICULATE FORMULATION | ISIS PHARMACEUTICALS, INC. (US) | 2001-11-28 | — | — | EP | claimed |
| WO-2001001932-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2001-01-11 | — | — | WO | claimed |
| WO-2000050050-A1 | MULTIPARTICULATE FORMULATION | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| US-5780658-A | Process for the synthesis of cationic surfactants comprising esterification with basic character amino acids | LABORATORIOS MIRET, S.A. (ES) | 1998-07-14 | — | — | US | claimed |
| CN-1091952-A | Cosmetic composition | UNILEVER NV (NL) | 1994-09-14 | — | — | CN | claimed |
| WO-1994019027-A1 | METHOD AND COMPOSITION FOR DISINFECTING CONTACT LENSES | WESLEY-JESSEN CORPORATION (US) | 1994-09-01 | — | — | WO | claimed |
| EP-0230037-B1 | CYTOPROTECTIVE DERIVATIVES USEFUL IN ISCHEMIC DISEASES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | ITALFARMACO S.p.A. (IT) | 1991-03-06 | — | — | EP | claimed |
| EP-0004589-B1 | ALPHA-N-ACETYL-L-PHENYLALANINE-L-ARGININE-ETHYL ESTER, PROCESS FOR ITS PREPARATION AND ITS USE AS A DIAGNOSTIC AGENT FOR KALLIKREIN | BAYER AG (DE) | 1982-02-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | GDA, XPA, ERCC2 | DPP7 4414/4885NOD1 1822/4885NPY4R 3960/4885 |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | GLA, ALDOA, MAN2A1 | DPP7 3192/4885NOD1 4160/4885NPY4R 4234/4885 |
| US-12630661-B2 | Additives useful in 3D printing technologies | HTR3D, HTR3B, HTR3C | DPP7 3989/4885NOD1 1514/4885NPY4R 394/4885 |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | GLP1R, TTR, IAPP | DPP7 472/4885NOD1 1201/4885NPY4R 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.